Ustekinumab 45MG/0.5ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F2N77
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,467
Award facts
- Contract value 100% obligated
- $10,467.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,467.40 delivery order to Amerisourcebergen Drug Corp on March 31, 2026, for USTEKINUMAB 45MG/0.5ML syringe supply with an ultimate completion date of April 21, 2026, under firm fixed-price terms.
Place of performance is Conshohocken, PA. The order carries no set-aside designation and was issued against the company's existing indefinite delivery contract with DLA Troop Support Medical.
Quick answers
Who was awarded contract SPE2DR26F2N77?
SPE2DR26F2N77 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 31, 2026.
How much is contract SPE2DR26F2N77 worth?
The government has obligated $10,467 on SPE2DR26F2N77.
Is contract SPE2DR26F2N77 an order under another contract?
Yes. SPE2DR26F2N77 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F2N77 competed?
The extent of competition for SPE2DR26F2N77 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award